We have previously demonstrated that the inducible nitric oxide synthase (iNOS) protein and total NOS activity increase in the hypothalamus and other regions of the male rat brain during aging. We have now tested the hypothesis that increased iNOS results in excessive nitric oxide (NO) and peroxynitrite production, and leads to increased apoptosis in CNS cells, including the GnRH and oxytocin hypothalamic neurons involved in the control of male reproductive function. Young (3-month-old) and old (24-month-old) male Brown Norway rats (n = 6) were perfused with 4% formalin. Adjacent coronal paraffin-embedded sections (5 µm) of preoptic area (POA), supraoptic nucleus (SON), paraventricular nucleus (PVN), and arcuate nucleus (ARC) of the hypothalamus were immunostained with antibodies for iNOS, neuronal NOS (nNOS), and nitrotyrosine (a marker of peroxynitrite formation). The intensity of immunostaining was measured using a densitometric image analysis system. Apoptosis was determined by the TUNEL assay. Double immunofluorescence staining with confocal laser scanning microscopy was used for co-localization studies. A significant increase in the iNOS immunostaining measured as optical density (OD) was found in the old compared to the young animals (SON: 0.32 ± 0.02 vs. 0.23 ± 0.03, p < 0.05; PVN: 0.34 ± 0.03 vs. 0.07 ± 0.05, p < 0.001; POA: 0.18 ± 0.02 vs. 0.01 ± 0.02, p < 0.001). Aging did not affect nNOS expression. Nitrotyrosine was elevated in the hypothalamic regions of old compared to young rats (SON: 0.32 ± 0.05 vs. 0.10 ± 0.04, p < 0.05; PVN: 0.32 ± 0.04 vs. 0.13 ± 0.03, p < 0.01; POA: 0.72 ± 0.06 vs. 0.03 ± 0.003, p < 0.001). Increased nitrotyrosine was accompanied by an elevation of the apoptotic index in the old rats (SON: 11.01 ± 3.33 vs. 0.57 ± 0.50, p < 0.001; PVN: 3.08 ± 1.12 vs. 0.42 ± 0.32; POA: 6.60 ± 1.93 vs. 0.18 ± 0.17, p < 0.01; ARC: 0.001 ± 0.0001 vs. 4.33 ± 2.33). iNOS staining co-localized with GnRH and oxytocin staining. In conclusion: The aging-related iNOS increased expression in the hypothalamus of the male rat affects regions known to control the synthesis and release of GnRH (POA, ARC) and oxytocin (PVN, SON), and the factors regulating penile erection (POA, and PVN). These observations suggest that iNOS may play a role in the reduction in GnRH and oxytocin neuronal secretion resulting in reproductive dysfunctions such as lowered serum testosterone, hypospermatogenesis, and diminished copulatory function in the aging male animal.

Keywords:
Nitric oxide, Gonadotropin-releasing hormone, Apoptosis, Oxytocin, Male reproduction, Arcuate nucleus, Paraventricular nucleus, Preoptic area, Immunocytochemistry
1.
Afifi AK, Bergman RA: Functional Neuroanatomy. New York, McGraw-Hill, 1998, pp 403–415.
2.
Sharpe RM: Regulation of spermatogenesis; in Knobil E, Neil JD (eds): The Physiology of Reproduction, New York, Raven Press, 1994, pp 1363–1434.
3.
Lugg J, Rajfer J, Gonzalez-Cadavid NF: Dihydrostestosterone is the active androgen in the maintenance of nitric-oxide mediated penile erection in the rat. Endocrinology 1995;136:1495–1501.
4.
Wang C, Leung A, Sinha-Hikim AP: Reproductive aging in the male Brown-Norway rat: A model for the human. Endocrinology 1993;133:2773–2781.
5.
Wang C, Sinha Hikim AP, Lue YH, Leung A, Baravarian S, Swerdloff RS: Reproductive aging in the Brown Norway rat is characterized by accelerated germ cell apoptosis and is not altered by luteinizing hormone replacement. J Androl 1999;4:509–518.
6.
Chen H, Huhtaniemi I, Zirkin BR: Depletion and repopulation of Leyding cells in the tests of aging Brown Norway rats. Endocrinology 1996;137:3447–3452.
7.
Zirkin BR, Santulli R, Strandberg JD, Wright WW, Ewing LL: Testicular steroidogenesis in the aging Brown Norway rat. J Androl 1993;2:118–123.
8.
Gruenewald DA, Naai MA, Hess DL, Matsumoto AM: The Brown Norway rat as a model of male reproductive aging: Evidence for both primary and secondary testicular failure. J Gerontol 1994;49:B42–50.
9.
Bonavera JJ, Swerdloff RS, Sinha Hikim AP, Lue YH, Wang C: Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate. J Neuroendocrinol 1998;10:93–99.
10.
Bonavera JJ, Swerdloff RS, Leung A, Lue YH, Baravarian S, Superlano L, Sinha-Hikim AP, Wang C: In the male brown-Norway (BN) male rat, reproductive aging is associated with decreased LH-pulse amplitude and area. J Androl 1997;18:359–365.
11.
Gruenewald DA, Matsumoto AM: Age-related decreases in serum gonadotropin levels and gonadotropin-releasing hormone gene expression in the medial preoptic area of the male rat are dependent upon testicular feedback. Endocrinology 1991;5:2442–2450.
12.
Gruenewald DA, Naai MA, Marck BT, Matsumoto AM: Age-related decrease in hypothalamic gonadotropin-releasing hormone (GnRH) gene expression, but not pituitary responsiveness to GnRH, in the male Brown Norway rat. J Androl 2000;21:72–84.
13.
Marson L: Central nervous system control; in Carson CC, Kirby RS, Goldstein I (eds): Textbook of Male Erectile Dysfunction. New York, Isis Medica, 1999, pp 73–78.
14.
Marson L, Carson CC: Central nervous system innervation of the penis, prostate, and perineal muscles: A transneuronal tracing study. Mol Urol 1999;3:43–50.
15.
Giuliano F, Rampin O, Brown K, Courtois F, Benoit J, Jardin A: Stimulation of the medial preoptic area of the hypothalamus in the rat elicits increases in intracavernosal pressure. Neurosci Lett 1996;209:1–4.
16.
Giuliano F, Bernabe J, Brown K, Droupy S, Benoit G, Rampin O: Erectile response to hypothalamic stimulation in rats: Role of peripheral nerves. Am J Physiol 1997;273:R1990–1997.
17.
Giuliano FA, Rampin O, Benoit G, Jardin A: Neural control of penile erection. Urol Clin North Am 1995;22:747–766.
18.
Melis MR, Succu S, Iannucci U, Argiolas A: N-methyl-D-aspartic acid-induced penile erection and yawning: Role of hypothalamic paraventricular nitric oxide. Eur J Pharmacol 1997;328:115–123.
19.
Chen KK, Chan JY, Chang LS: Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. J Urol 1999;162:237–242.
20.
Smith ER, Stefanick ML, Clark JT, Davidson JM: Hormones and sexual behavior in relationship to aging in male rats. Horm Behav 1992;26:110–135.
21.
Melis MR, Succu S, Iannucci U, Argiolas A: Oxytocin increases nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats: Correlation with penile erection and yawning. Regul Pept 1999;69:103–111.
22.
Melis MR, Spano MS, Succu S, Argiolas A: The oxytocin antagonist d(CH2)5Tyr(Me)2-Orn8-vasotocin reduces non-contact penile erections in male rats. Neurosci Lett 1999;265:171–174.
23.
Melis MR, Argiolas A: Role of central nitric oxide in the control of penile erection and yawning. Progr Neuro-Psychopharm Biol Psych 1997;21:899–922.
24.
Bazhanova ED, Grinevich VV, Danilova OA, Chernigovskaya EV: Age-related changes in oxytocinergic neurosecretory cells in the accessory magnocellular neuroendocrine nuclei of the hypothalamus in rats. Neurosci Behav Physiol 1998;4:354–356.
25.
Silverman WF, Aravich PA, Sladek JR Jr, Sladek CD: Physiological and biochemical indices of neurohypophyseal function in the aging Fischer rat. Neuroendocrinology 1990;52:181–190.
26.
Calza L, Giardino L, Velardo A, Battistini N, Marrama P: Influence of aging on the neurochemical organization of the rat paraventricular nucleus. J Chem Neuroanat 1990;3:215–231.
27.
Tang Y, Rampin O, Calas A, Facchinetti P, Giuliano F: Oxytocinergic and serotonergic innervation of identified lumbosacral nuclei controlling penile erection in the male rat. Neuroscience 1998;82:241–255.
28.
Lorrain DS, Matuszewich L, Friedman RD, Hull EM: Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. J Neurosci 1997;93:61–66.
29.
González-Cadavid NF, Ignarro LJ, Rajfer J: Nitric oxide and the cyclic GMP system in the penis. Mol Urol 1999;3:51–59.
30.
Garbán H, Vernet D, Freedman A, Rajfer J, González-Cadavid NF: Effect of aging on nitric oxide-mediated penile erection in the rat. Am J Physiol 1995;268:H467–H475.
31.
Garbán H, Marquez D, Magee T, Moody J, Rajavashisth T, Roadriguez JA, Hung A, Vernet D, Rajfer J, González-Cadavid NF: Cloning of rat and human inducible penile oxide synthase: Application for gene therapy of erectile dysfunction. Biol Reprod 1996;56:954–963.
32.
Torreilles F, Salman-Tabcheh S, Guerin M, Torreilles J: Neurodegenerative disorders: The role of peroxynitrite. Brain Res Brain Res Rev 1999;30:151–163.
33.
Butterfield DA, Howard B, Yatin S, Koppal T, Drake J, Hensley K, Aksenov M, Aksenova M, Subramaniam R, Varadarajan S, Harris-White ME, Pedigo NW Jr, Carney JM: Elevated oxidative stress in models of normal brain aging and Alzheimer’s disease. Life Sci 1999;65:1883–1892.
34.
Bian K, Davis K, Kuret J, Binder L, Murad F: Nitrotyrosine formation with endotoxin-induced kidney injury detected by immunohistochemistry. Am J Physiol 1999;277:F33–F40.
35.
Sastre J, Pallardo FV, Garcia de la Asuncion J, Vina J: Mitochondria, oxidative stress and aging. Free Radic Res 2000;32:189–198.
36.
Thomas RJ: Excitatory amino acids in health and disease. J Am Geriatr Soc 1995;43:1279–1289.
37.
Vernet D, Bonavera JJ, Swerdloff RS, González-Cadavid NF, Wang C: Spontaneous expression of inducible nitric oxide synthase (iNOS) in the hypothalamus and other brain regions of aging rats. Endocrinology 1998;139:3254–3261.
38.
Uttenthal LO, Alonso D, Fernandez AP, Campbell RO, Moro MA, Leza JC, Lizasoain I, Esteban FJ, Barroso JB, Valderrama R, Pedrosa JA, Peinado MA, Serrano J, Richart A, Bentura ML, Santacana M, Martinez-Murillo R, Rodrigo J: Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc Res Tech 1998;43:75–88.
39.
Ferrini M, Piroli G, Frontera M, Falbo A, Lima AE, DeNicola AF: Estrogens normalize the response to stress and increase gluccorticoid receptors immunoreactivity in aging rats. Neuroendocrinology 1999;69:129–137.
40.
Ferrini M, Magee TR, Vernet D, Rajfer J, González-Cadavid NF: Aging-related expression of inducible nitric oxide sythase (iNOS) and markers of tissue damage in the rat penis. Biol Reprod 2001;64:974–982.
41.
González-Cadavid NF, Burnett AL, Magee T, Zeller CB, Vernet D, Gitter J, Smith N, Rajer J: Expression of penile neuronal nitric oxide synthase variants in the rat and mouse penile nerves. Biol Reprod 2000;63:704–714.
42.
Paxinos G, Watson C: The rat brain in stereotaxic coordinates; compact ed 3. New York, Academic Press, 1997.
43.
Dudas B, Mihaly A, Merchenthaler I: Topography and association of luteinizing hormone-releasing hormone and neuropeptide Y-immunoreactive neuronal systems in the human diencephalon. J Comp Neurol 2000;427:593–603.
44.
Vernet D, Sinha-Hikim AP, Swerdloff RS, González-Cadavid NF, Wang C: Age-related increase in germ cell apoptosis in male Brown-Norway rats is associated with increased expression of inducible nitric oxide synthase. J Androl 2000.
45.
Harada S, Imaki T, Chikada N, Naruse M, Demura H: Distinct distribution and time-course changes in neuronal nitric oxide synthase and inducible NOS in the paraventricular nucleus following lipopolysaccharide injection. Brain Res 1999;821:322–332.
46.
Bazhanova ED, Grinevich VV, Danilova OA, Chernigovskaya EV: Age-related changes in oxytocinergic neurosecretory cells in the accessory magnocellular neuroendocrine nuclei of the hypothalamus in rats. Neurosci Behav Physiol 1998;4:354–356.
47.
Calza L, Giardino L, Velardo A, Battistini N, Marrama P: Influence of aging on the neurochemical organization of the rat paraventricular nucleus. J Chem Neuroanat 1990;3:215–231.
48.
Taglialatela G, Robinson R, Gegg M, Perez Polo JR: Nerve growth factor, central nervous system apoptosis, and adrenocortical activity in aged Fischer-344/brown Norway F1 hybrid rats. Brain Res Bull 1997;43:229–233.
49.
Bentz BG, Simmons RL, Haines GK, Radosevich JA: The yin and yang of nitric oxide: Reflections on the physiology and pathophysiology of NO. Head Neck 2000;22:71–83.
50.
Li J, Bombeck CA, Yang S, Kim YM, Billiar TR: Nitric oxide suppression apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes. J Biol Chem 1999;274:17325–17333.
51.
Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME: Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 1997;17:9157–9164.
52.
Veldhuis JD: Novel modalities for appraising individual and coordinate pulsatile hormone secretion: The paradigm of luteinizing hormone and testosterone release in the aging male. Mol Psychiatry 1997;2:70–80.
53.
Vermuelen A: Androgens in the aging male. J Clin Endorinol Metab 1991;73:221–224.
54.
Brann DW, Bhat GK, Lamar CA, Mahesh VB: Gaseous transmitter and neuroendocrine regulation. Neuroendocrinology 1997;65:385–395.
55.
Rettori V, Canteros G, Renoso R, Gimeno M, McCann SM: Oxytocin stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamic explants by releasing nitric oxide. Proc Natl Acad Sci USA 1997;94:2741–2744.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.